Hawaii Biotech
Chemicals & Related Products · Hawaii, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
650 Iwilei Rd Ste 204, Honolulu, Hawaii,...Phone Number
(808) 486-5333Website
www.hibiotech.comRevenue
<$5 MillionIndustry
About Hawaii Biotech
Hawaii Biotech Inc. specializes in developing vaccines and medical countermeasures for emerging and re-emerging infectious diseases, including treatments for Anthrax and botulism. The company utilizes a recombinant subunit protein platform to produce high-quality proteins that maintain their native-like structure, outperforming traditional vaccine methods. Their innovative semi-synthetic adjuvant, GPI-0100, is designed to elicit broad immune responses for both vaccines and therapeutics. Target clients include healthcare providers and organizations focused on infectious disease prevention and treatment.Explore more
Hawaii Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Hawaii Biotech
Compare insights from companies similar to Hawaii Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Hawaii Biotech
<$5M
11-50
Private
$50.4M
1982
LK
Laurence KnutsonChief Operating Officer & Chief Financial Officer
Hawaii Biotech Tech Stack
A closer look at the technologies used by Hawaii Biotech
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hawaii Biotech
Sign Up For FreeTo access detailed company insights
Hawaii Biotech Inc. specializes in developing vaccines and medical countermeasures for emerging and re-emerging infectious diseases, including treatments for Anthrax and botulism. The company utilizes a recombinant subunit protein platform to produce high-quality proteins that maintain their native-like structure, outperforming traditional vaccine... Read More
